-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Our Latest Whitepapers
Get the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreBlogs, Case Studies & Podcasts
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights
IQVIA APAC Insight
"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.
Read The Latest Issue
Career Opportunities
Improving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
Search Jobs
Fact Sheet
IQVIA Adult Vaccination: Navigating Vaccine Market Dynamics
Jul 03, 2023
In Southeast Asia, there is a burgeoning need to address the adoption and affordability of adult vaccinations. These vaccinations include but not limited to Tetanus, Diphtheria, Pertussis (Tdap or Td), Measles, Mumps, Rubella (MMR), Varicella/Chickenpox, Pneumococcal, Hepatitis A, Hepatitis B, Meningococcal, and Zoster Recombinant/Shingles.
Although these vaccines are included in the national immunization programs, not all adults maintain their immunity as they age. For some vaccines, boosters are required, especially for those falling into high-risk groups.
Download this fact sheet to find out how to bridge the gap in understanding, acceptance, and uptake among adults who play a crucial role as decision-makers for vaccine purchases.
For more information on IQVIA Adult Vaccination, contact us.
Institute Reports
Trends in Global Adult Vaccination
This research brief from the IQVIA Institute – Trends in Global Adult Vaccination: Impact of COVID-19 – aims to provide a baseline of adult vaccination trends and missed vaccination doses during the COVID-19 pandemic while assessing variations by countries and regions.